DocGo (NASDAQ:DCGO – Get Free Report) is anticipated to announce its Q4 2025 results after the market closes on Monday, March 16th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $70.3560 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Monday, March 16, 2026 at 5:00 PM ET.
DocGo Price Performance
Shares of NASDAQ:DCGO opened at $0.67 on Monday. DocGo has a 1 year low of $0.66 and a 1 year high of $3.18. The firm has a market capitalization of $65.72 million, a price-to-earnings ratio of -1.29 and a beta of 0.95. The business’s 50 day moving average price is $0.80 and its 200-day moving average price is $1.07.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on DCGO. Canaccord Genuity Group cut their price target on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a report on Wednesday, November 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $2.25.
Institutional Trading of DocGo
Several large investors have recently made changes to their positions in DCGO. Cerity Partners LLC purchased a new position in DocGo in the 2nd quarter valued at $37,000. Strs Ohio acquired a new stake in DocGo during the 1st quarter worth $76,000. Engineers Gate Manager LP purchased a new stake in shares of DocGo during the second quarter worth $52,000. Neuberger Berman Group LLC acquired a new stake in shares of DocGo in the fourth quarter valued at about $29,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in shares of DocGo in the fourth quarter valued at about $40,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Further Reading
- Five stocks we like better than DocGo
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
